Zurueck zur Suche

Reporte zur Charge U015682

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

23Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 15 IL 2 TN 1 NC 1 VA 1 NJ 1 CT 1

VAERS 2114525

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

mild
Staat
-
Alter
1,2
Geschlecht
M
Eingang
16.02.2022
Impfdatum
31.01.2022
Beginn
15.02.2022
Tage bis Beginn
15,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

15mo M with rash, small bumps- left and right side and lower back. Improving currently from yesterday but still present. Denies itching or fevers. He continues to eat, drink, void/stool normally. He received MMR and Varicella vaccines on 31Jan2022, symptoms developed on 15Feb22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1897000

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

mild
Staat
TN
Alter
18,0
Geschlecht
F
Eingang
24.11.2021
Impfdatum
04.11.2021
Beginn
06.11.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Hypoaesthesia Visual field defect Visual impairment

Symptomtext

On Saturday morning following the vaccinations (roughly 48 hours after shots) reported having blind spots Saturday and Sunday (not tunnel vision) saying she couldn't see clearly but it was not blurry, fingertips on left hand went numb for 1-2 minutes on Saturday, headache behind eyes Saturday and Sunday. Patient stated by end of day Sunday all symptoms dissipated. patient was not vaccinated as a child so only recently in the last few years has she started receiving vaccines and this was the first time receiving either of these vaccines. she is in nursing school and getting them for college. did say she started birth control pills for the first time roughly 3 months ago.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
ZYRTEC PRN "HAILEY" BIRTH CONTROL PILLS DAILY
Allergien
PENICILLIN
Vorherige Impfungen
-

VAERS 2624019

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
NC
Alter
0,3
Geschlecht
M
Eingang
01.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

no symptoms noted

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2568189

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
26.01.2023
Impfdatum
03.01.2023
Beginn
16.01.2023
Tage bis Beginn
13,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No additional AEs were reported; The patient received first MMR II and VARIVAX on 1/3/2023 and second MMR II and VARIVAX on 1/16/2023.; This spontaneous report has been received from another health professional referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported. On 03-JAN-2023 the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot #U015682 had been verified to be a valid number; expiration date 18-MAY-2023, and upon internal validation established as the same date) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot #U039664 had been verified to be a valid number; expiration date 15-DEC-2023, and upon internal validation established as the same date) both vaccines administered for prophylaxis (dose, vaccination scheme, frequency, route of administration, anatomical site of injection, lot number, and expiration date were not reported). Other suspect therapies included sterile diluent (STERILE DILUENT). On 16-JAN-2023, 14 days after the first dose the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot #U015682 had been verified to be a valid number; expiration date 18-MAY-2023, and upon internal validation established as the same date) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot #U039664 had been verified to be a valid number; expiration date 15-DEC-2023, and upon internal validation established as the same date) both vaccines administered for prophylaxis (dose, vaccination scheme, frequency, route of administration, anatomical site of injection, lot number, and expiration date were not reported) (inappropriate schedule of product administration). Other suspect therapies included sterile diluent (STERILE DILUENT). There was no adverse effect reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2563491

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
IL
Alter
19,0
Geschlecht
M
Eingang
19.01.2023
Impfdatum
16.01.2023
Beginn
16.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

There was not an adverse event- MMR II and Varicella ( varivax) Patient had already received the following vaccines on January 3, 2023. Then came back to the office on January 16,2023 & stated he needed another round of the same vaccines. CMA administered without checking EMR of the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
No Adverse event from receiving the vaccines.
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2160514

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
05.03.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other adverse experiences; Improperly stored VARIVAX; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided. On 07-FEB-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, for prophylaxis (valid lot #U015682, expiration date: 18-MAY-2023) (route of administration, vaccination scheme frequency, and anatomical location were not reported). The administered dose of the vaccine experienced a temperature excursion 9.7 degrees Fahrenheit (F) for 20 minutes. There was no other adverse experiences reported. This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2141854

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
26.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no other adverse experiences reported; two doses of improperly stored VARIVAX was administered to two patients; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 07-FEB-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot # U015682, expiration date 18-MAY-2023 (site of administration was not provided) for prophylaxis. Administered dose of suspect vaccine experienced temperature excursion of 9.7 Fahrenheit degrees (F) for 40 minutes (Product storage error). No previous temperature excursions were reported. It was unknown if digital data logger was involved. No other adverse experiences were reported (No adverse event). This is one of two reports from the same reporter.; Sender's Comments: US-009507513-2202USA002198:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2084656

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
03.02.2022
Impfdatum
-
Beginn
09.12.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse event reported; Incorrect product storage; This spontaneous report was received from a nurse practitioner referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported. On an unspecified date, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (Lot# U015682 and expiration date 18-MAY-2023) (exact dose and frequency were not reported) as prophylaxis. (product storage error). The vaccine underwent a temperature excursion of minus 14 degree Celsius to minus 10 degree Celsius for 0 hours 10 minutes and 0 seconds and minus 10 degree Celsius to minus 8 degree Celsius (7.4 Celsius) for 8 hours 20 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse event reported, no further information provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1876633

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
NJ
Alter
19,0
Geschlecht
M
Eingang
17.11.2021
Impfdatum
16.11.2021
Beginn
16.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Skin warm Swelling

Symptomtext

Localized swelling, hot to touch and redness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1810117

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
23.10.2021
Impfdatum
11.09.2021
Beginn
11.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; products experienced an excursion of 4C fo 20 minutes; This spontaneous report was received from a registered nurse concerning a 4-year-old patient. The patient's medical history, concurrent conditions, and concomitant medications were not reported. On 11-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX), lot # U015682, expiry date: 18-MAY-2023, for prophylaxis. The dose was stored between -10 to 8 degrees celsius (C) (4 C) for 20 minutes. A previous temperature excursion showed the dose was stored between -10 to 8 C (4 C) for 7 hours and 30 minutes. This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005662: US-009507513-2109USA005648:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1787436

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
2,0
Geschlecht
U
Eingang
15.10.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product temperature excursion issue

Symptomtext

No additional AE; temperature excursion for VARlVAX have been administered to patients; This spontaneous report was received from a nurse referring to a 2-year-old patient of unknown gender. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 07-SEP-2021 and 09-SEP-2021, the products including varicella virus vaccine live (Oka/Merck) (VARIVAX) experienced an excursion of 4 degree Celsius (C) from -10 C to 8 C for 20 minutes during each transport. On 13-SEP-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (strength, route, frequency were not provided; Lot# U015682 has been verified to be a valid lot number, expiration date reported as 18-MAY-2023) for prophylaxis. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005648: US-009507513-2109USA005618: US-009507513-2109USA005639: US-009507513-2109USA005632: US-009507513-2109USA005910: US-009507513-2109USA005742: US-009507513-2109USA005891: US-009507513-2109USA005964: US-009507513-2109USA005651: US-009507513-2109USA005918: US-009507513-2109USA005744: US-009507513-2109USA005758: US-009507513-2109USA005760: US-009507513-2109USA005705: US-009507513-2109USA005776: US-009507513-2109USA005901: US-009507513-2109USA005662: US-009507513-2109USA005641: US-009507513-2109USA005945: US-009507513-2109USA005881: US-009507513-2109USA005902: US-009507513-2109USA005648:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product temperature excursion issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1775896

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
11.10.2021
Impfdatum
15.09.2021
Beginn
15.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's reported.; calling to report a temperature excursion for VARIVAX; This spontaneous report was received from a nurse referring to a 4-years-old patient of unknown gender. For all the patients, the concurrent conditions, medical history and concomitant medications were not provided. On 15-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (strength, dose, route, frequency, were not provided) for prophylaxis; Lot No. U015682 has been verified to be a valid lot number for [varicella virus vaccine live (Oka/Merck)], expiration date reported as 18-MAY-2023, and upon internal validation established as the same. The nurse reported that the vaccine dose was administered on 15-SEP-2021 and there was a temperature excursion for varicella virus vaccine live (Oka/Merck) (VARIVAX). The product experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of 26 reports received from the same source.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005639: US-009507513-2109USA005632: US-009507513-2109USA005910: US-009507513-2109USA005891: US-009507513-2109USA005964: US-009507513-2109USA005651: US-009507513-2109USA005918: US-009507513-2109USA005744: US-009507513-2109USA005648: US-009507513-2109USA005758: US-009507513-2109USA005760: US-009507513-2109USA005705: US-009507513-2109USA005776: US-009507513-2109USA005662: US-009507513-2109USA005901: US-009507513-2109USA005752: US-009507513-2109USA005662: US-009507513-2109USA005641: US-009507513-2109USA005648:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1755664

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
02.10.2021
Impfdatum
-
Beginn
09.09.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's; products experienced an excursion/have been administered to patients; This spontaneous report was received from a nurse referring to an 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 16-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (Lot# U015682 has been verified to be a valid lot number for varicella virus vaccine live (Oka/Merck) (VARIVAX), expiration date reported as 18-MAY-2023) (strength, dose, route, frequency, were not provided) for prophylaxis. The nurse reported that the vaccine experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of 26 reports received from the same source.; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751660

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
0,5
Geschlecht
U
Eingang
01.10.2021
Impfdatum
-
Beginn
17.09.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported; temperature excursion for VARlVAX / have been administered to the patients; This spontaneous report was received from a registered nurse and refers to a 6-month-old patient of unknown gender. There was no information about the patient's concurrent conditions, allergies, drug reactions, concomitant therapies or medical history provided. On 17-SEP-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot# U015682 verified as valid, with expiration date:18-MAY-2023) in dose: 1 (units not provided) for prophylaxis (exact dose, dose number, route of administration and anatomical location were not reported). The temperature to which the vaccine was exposed was -10C to 8C (4 degrees of Celsius (C)) for 20 minutes on 07-SEP-2021 during the transport, and -10C to 8C (4 degrees of Celsius (C)) for 20 minutes on 09-SEP-2021 also during the transport. The vaccine underwent previous temperature excursion of temperature -10C to 8C ( 4C) for 7 hours and 30 minutes. It was unknown if a digital data logger was involved. No adverse symptoms were reported. The outcome of product storage error was unknown. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751659

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
01.10.2021
Impfdatum
16.09.2021
Beginn
16.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; products experienced an excursion/have been administered to patients; This spontaneous report was received from a nurse referring to an 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 16-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (Lot# U015682 has been verified to be a valid lot number for varicella virus vaccine live (Oka/Merck) (VARIVAX), expiration date reported as 18-MAY-2023) (strength, dose, route, frequency, were not provided) for prophylaxis. The nurse reported that the vaccine experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of 26 reports received from the same source.; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1747557

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
2,0
Geschlecht
U
Eingang
30.09.2021
Impfdatum
09.09.2021
Beginn
09.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported.; temperature excursion for VARlVAX/an excursion of 4 Celsius degrees for 20 minutes during transport and 4 Celsius degrees for 20 minutes during transport/administered on 09-SEP-2021; This spontaneous report was received from a registered nurse (also reported as medical assistant) and refers to a 2-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 07-SEP-2021 during transport, the varicella virus vaccine live (oka/merck) (VARIVAX) lot# U015682, expiration date: 18-MAY-2023, lot# U002394, expiration date: 22-JAN-2023 and lot # U010400, expiration date: 01-APR-2023, experienced an excursion of 4 Celsius degrees (C) for 20 minutes. On 09-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot# U015682, expiration date reported as 18-MAY-2023 (formulation, dose, anatomical location, and route of administration were not reported) for prophylaxis (product storage error). Administered dose of vaccine experienced the temperature excursion of -10 (C) to 8C (4C) for 20 minutes and -10C to 8C (4C) for 20 minutes. Previous temperature excursion: -10C to 8C (4C) for 7 hours and 30 minutes. No additional adverse event was reported (no adverse event). This is one of several reports from the same reporter concerning this vaccine.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005618: US-009507513-2109USA005632: US-009507513-2109USA005742: US-009507513-2109USA005744: US-009507513-2109USA005758: US-009507513-2109USA005776: US-009507513-2109USA005902: US-009507513-2109USA005945: US-009507513-2109USA005964:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1743409

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
29.09.2021
Impfdatum
09.09.2021
Beginn
09.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no addtional AE; products experienced an excursion had been administered to patient; This spontaneous report was received from a registered nurse (also reported as medical assistant) referring to a 4-year old patient of unknown gender. The patient's pertinent medical history, drug allergies/reactions and concomitant medication were not provided. Per reporter, varicella virus vaccine live (oka/merck) (VARIVAX) with lot# U015682, U002394, and U010400 experienced an excursion of minus 10 degree Celsius to 8 degree Celsius (4 degree Celsius) for 20 minutes on 07-SEP-2021 during transport and minus 10 degree Celsius to 8 degree Celsius (4 degree Celsius) for 20 minutes on 09-SEP-2021 during transport. On 09-SEP-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U015682, expiration date 18-MAY-2023, dose: 1 (unit unknown); strength and route were unknown) for prophylaxis (product storage error). Previous temperature excursion of this vaccine was reported as minus 10 degree Celsius to 8 degree Celsius (4 degree Celsius) for 7 hours and 30 minutes. No additional adverse event reported. This is one of several reports received from same reporter. ; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005910: US-009507513-2109USA005742: US-009507513-2109USA005891: US-009507513-2109USA005632: US-009507513-2109USA005964: US-009507513-2109USA005651: US-009507513-2109USA005918: US-009507513-2109USA005744: US-009507513-2109USA005758: US-009507513-2109USA005648: US-009507513-2109USA005705: US-009507513-2109USA005776: US-009507513-2109USA005901: US-009507513-2109USA005639: US-009507513-2109USA005662: US-009507513-2109USA005752: US-009507513-2109USA005641: US-009507513-2109USA005945: US-009507513-2109USA005618: US-009507513-2109USA005881: US-009507513-2109USA005902:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1740507

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
28.09.2021
Impfdatum
09.09.2021
Beginn
09.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; an excursion of 4 Celsius degrees for 20 minutes during transport and 4 Celsius degrees for 20 minutes during transport/ administered on 09-SEP-2021; This spontaneous report was received from a registered nurse (also reported as medical assistant) and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 07-SEP-2021 during transport, the varicella virus vaccine live (oka/merck) (VARIVAX) lot# U015682, expiration date: 18-MAY-2023, lot# U002394, expiration date: 22-JAN-2023 and lot # U010400, expiration date: 01-APR-2023 , experienced an excursion of (4 Celsius degree) for 20 minutes. On 09-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot# U015682, expiration date reported as 18-MAY-2023 (formulation, dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). Administered dose of vaccine experienced the temperature excursion of -10 Celsius degree (C) to 8C ( 4C) for 20 minutes and -10C to 8C ( 4C) for 20 minutes. Previous temperature excursion: -10C to 8C ( 4C) for 7 hours and 30 minutes. No additional adverse event was reported (no adverse event). This is one of the several reports from the same reporter concerning this vaccine.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005618: US-009507513-2109USA005632: US-009507513-2109USA005744: US-009507513-2109USA005742: US-009507513-2109USA005776: US-009507513-2109USA005881: US-009507513-2109USA005945: US-009507513-2109USA005964:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736179

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
1,0
Geschlecht
U
Eingang
27.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; temperature excursion for VARlVAX; This spontaneous report was received from a registered nurse (conflicting information as the reporter's title was reported as medical assitant) referring to a 52-week-old patient of unknown gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 14-SEP-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot number U015682, expiration date 18-MAY-2023 (dose and route of administration not provided) for prophylaxis. No adverse event was reported. The vaccine experienced a temeprature excursion on 07-SEP-2021 of 4 degrees Celsius (?C) for 20 minutes and on 09-SEP-2021 for the same temperature and duration. The vaccine experienced a previous temeprature excursion of 4?C for 7 hours and 30 minutes; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736178

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
5,0
Geschlecht
U
Eingang
27.09.2021
Impfdatum
10.09.2021
Beginn
10.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; temperature excursion for VARlVAX; This spontaneous report was received from a registered nurse (conflicting information as the reporter's title was reported as medical assitant) referring to a 5-year-old patient of unknown gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 10-SEP-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot number U015682, expiration date 18-MAY-2023 (dose and route of administration not provided) for prophylaxis. No adverse event was reported. The vaccine experienced a temeprature excursion on 07-SEP-2021 of 4 degrees Celsius (?C) for 20 minutes and on 09-SEP-2021 for the same temperature and duration. The vaccine experienced a previous temeprature excursion of 4?C for 7 hours and 30 minutes; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736135

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
CT
Alter
-
Geschlecht
U
Eingang
27.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; administered after temperature excursion; 0.5 ml IM; This spontaneous report was received from a medical assistant, and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported. On 13-SEP-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, intramuscularly for prophylaxis (lot number U015682, was verified to be valid, expiration date reported and established as 18-MAY-2021); (site of administration was not provided). The administered dose of vaccine experienced a temperature excursion of 38 Fahrenheit degrees (F) for 4 hours. The patient did not experience any additional adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1733754

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
25.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's reported; Temperature excursion for VARIVAX; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, and concomitant medications were not reported. On 13-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, anatomical location, and route of administration were not reported) (lot# U015682 with an expiration date on 18-MAY-2023) for prophylaxis wich experienced a temperature excursi?n of 4?C Celsius degrees for 20 minutes on 07-SEP-2021 during transport and 4?C for 20minutes on 09-SEP-2021 during transport as well as -10?C to 8?C (4?C) for 20 minutes (product storage error). It was reported previous temperature excursions of -10?C to 8?C (4?C) for 7 hours and 30 minutes. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1733753

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015682

gering
Staat
MI
Alter
2,0
Geschlecht
U
Eingang
25.09.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AEs; temperature excursion for VARlVAX; This spontaneous report was received from a nurse referring to a 2-years-old patient of unknown gender. For all the patients, the concurrent conditions, medical history and concomitant medications were not provided. On 14-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (strength, dose, route, frequency, were not provided) for prophylaxis; Lot No. U015682 has been verified to be a valid lot number for [varicella virus vaccine live (Oka/Merck)], expiration date reported as 18-MAY-2023, and upon internal validation established as the same. The nurse reported that the vaccine dose was administered on 14-SEP-2021 and there was a temperature excursion for varicella virus vaccine live (Oka/Merck) (VARIVAX). The product experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of four reports received from the same source.; Sender's Comments: US-009507513-2109USA005618:reference TE number : 02017200 US-009507513-2109USA005628: US-009507513-2109USA005632:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-